We don't need to meet a primary endpoint in a phas

We don't need to meet a primary endpoint in a phase 2. The purpose of the phase 2 is to ensure we select appropriate end points for the phase 3.

What I want to see, is an undeniable improvement in AN end point.

Once we have an endpoint identified, they will create the end point for the new trial. Provided we have solid data, and progress to phase 3, this could end up being our nearest catalyst.

The phase 3 trial should enroll fairly quickly. If we are able to enroll in 2 months, we should have data back by the end of the year (or sooner).